Another swell.

Another swell.

Another swell.

Another swell.

Another day alone.

Another day of stares and whispers.

Another day of canceled plans.

Another day and night of terrors.

Real person living with HAE.

Is current HAE management forcing people to make trade‑offs?

An unpredictable, debilitating, and disfiguring disease, HAE can burden people’s personal, social, and professional lives1,3,4

While today’s HAE management has reduced the disease burden, people may still be making trade-offs among efficacy, tolerability, and convenience1,2,5-8

To feel confident with their management, people with HAE need options that quickly halt symptom progression AND are convenient, discreet, and well tolerated8,9

Don’t miss what’s next in HAE

Four real people with HAE. Four unique stories.

deflate HAE

TOGETHER

Answer these 6 quick questions and find out how you help take the air out of HAE.

What is your Deflate HAE Prescriber Profile?

CLICK Start Assessment HERE

What is your Deflate HAE Prescriber Profile?

HAE care requires balancing multiple clinical considerations, including individual patient needs and other treatment-related factors.3,6

Find out which profile best reflects your clinical practice for HAE management.

Quiz Visual
Profile Result Profile Result

Complete Your Profile

Become a part of the deflate HAE community

Share your information and join the more than 1,200 people who have already
signed up. Get the latest updates on deflate HAE, including community
stories, engaging interactive tools, and valuable resources.

All fields and checkboxes are required.

Woman holding balloons representing Tolerability, Convenience, & Efficacy

Critical Role of Bradykinin

Woman holding balloons representing Tolerability, Convenience, & Efficacy

Burden of HAE Management

References

  1. Lumry WR, et al. Allergy Asthma Proc. 2020;41(Suppl 1):S08-S13.
  2. Betschel SD, et al. J Allergy Clin Immunol Pract. 2023;11(8):2315-2325.
  3. Maurer M, et al. Allergy. 2022;77(7):1961-1990.
  4. Longhurst HJ, et al. Br J Hosp Med (Lond). 2019;80(7):391-398.
  5. Radojicic C, et al. Allergy Asthma Proc. 2021;42(3):S4-S10.
  6. Busse PJ, et al. J Allergy Clin Immunol Pract. 2021;9(1):132-150.e3.
  7. Geba D, et al. J Drug Assess. 2021;10(1):51-56.
  8. Covella B, et al. Future Pharmacol. 2024;4(1):41-53.
  9. Betschel SD, et al. Allergy Asthma Clin Immunol. 2024;20(43):1-8.
  10. Banerji A, et al. Allergy Asthma Proc. 2015;36(6):213-217.